CGRN - Certified Gastroenterology Registered Nurse Cgrn/Questions/Mcq 1

Question 1

A patient undergoing upper endoscopy is found to have Barrett's esophagus without dysplasia. What is the recommended surveillance interval?

Accepted Answer

Every 3–5 years

Answer

Non-dysplastic Barrett's esophagus carries a low risk of progression to adenocarcinoma. Current guidelines (ACG/AGA) recommend surveillance endoscopy every 3–5 years rather than more frequent intervals, which are reserved for low-grade or high-grade dysplasia.

Question 2

Which finding on liver biopsy is most characteristic of nonalcoholic steatohepatitis (NASH) compared to simple steatosis?

Accepted Answer

Lobular inflammation with hepatocyte ballooning

Answer

NASH is distinguished from simple steatosis by the presence of lobular inflammation and hepatocyte ballooning injury, often with pericellular fibrosis. These features indicate active liver injury and progression risk, whereas steatosis alone lacks these inflammatory components.

Question 3

A nurse is preparing a patient for a colonoscopy who takes warfarin for atrial fibrillation. The planned procedure includes polypectomy. What is the most appropriate anticoagulation management?

Accepted Answer

Hold warfarin 5 days before the procedure

Answer

For high-risk procedures such as polypectomy, warfarin should be held approximately 5 days prior to allow the INR to normalize. This is standard peri-procedural management to minimize bleeding risk while the half-life of warfarin clears.

Question 4

Which complication is most associated with prolonged use of proton pump inhibitors (PPIs)?

Accepted Answer

Clostridium difficile infection

Answer

Long-term PPI use is associated with an increased risk of Clostridium difficile infection due to the reduction of gastric acid, which normally serves as a barrier to colonization. Other associations include hypomagnesemia and vitamin B12 deficiency, but C. diff is a well-documented infectious complication.

Question 5

A patient with Crohn's disease presents with a new perianal fistula. Which medication class is most effective for inducing closure of perianal fistulas in Crohn's disease?

Accepted Answer

Anti-TNF biologics

Answer

Anti-TNF agents such as infliximab have demonstrated efficacy specifically for inducing and maintaining perianal fistula closure in Crohn's disease in landmark trials. 5-ASA agents are not effective for fistulizing disease, and corticosteroids may worsen fistulas.

CGRN - Certified Gastroenterology Registered Nurse Practice Test

CGRN - Certified Gastroenterology Registered Nurse Practice Test

CGRN - Certified Gastroenterology Registered Nurse Cgrn/Questions/Mcq 1